Aurealis Pharma (private company)

See something wrong or missing? Let us know
Offices:
Kuopio, Basel
Category:
Biotech Pharma
Business model:
B2B

Total investments received (USD) - 11.08M

Loading...

Aurealis Pharma, a biopharmaceutical company based in Kuopio, Finland and Basel, Switzerland, has developed an effective, safe and economical treatment method that greatly improves the quality of life for chronic inflammation and cancer sufferers.

Companies with similar profile to Aurealis Pharma:

CompanyCriteria
Finland TILT Biotherapeutics
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Nightingale Health
44%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • At least one other investor: Finnvera
  • Total raised in a similar range: 5M - 10M USD
Finland Synoste Oy
44%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • At least one other investor: Finnvera
  • Total raised in a similar range: 10M+ USD
Finland BioMensio
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Tekes
Finland TrademarkNow
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • Total raised in a similar range: 5M - 10M USD
Sweden Ilya Pharma
34%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
Finland Bonusway
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • Total raised in a similar range: 5M - 10M USD
Sweden Athera
34%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
Finland Blueprint Genetics
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • Total raised in a similar range: 10M+ USD
Finland Iceye
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • Total raised in a similar range: 10M+ USD
Finland Desentum
34%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
Finland HLD Healthy Life Devices
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • At least one other investor: Finnvera
Finland Connected Finland
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • At least one other investor: Finnvera
Finland Oura Health
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • Total raised in a similar range: 5M - 10M USD
Finland OceanVolt
34%
  • Similar business models: B2B
  • At least one vc investor: Tekes
  • At least one other investor: Finnvera
Sweden BoneSupport
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden InDex Pharmaceuticals
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Trialbee
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Norway Vaccibody
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD